Literature DB >> 2544904

Novelty-induced place preference behavior in rats: effects of opiate and dopaminergic drugs.

M T Bardo1, J L Neisewander, R C Pierce.   

Abstract

In Experiment 1, adult male rats were given eight 30-min exposures to one of two distinct environments. Control animals received either four exposures to each environment or were not exposed to either environment. When given free-choice access to both environments simultaneously, animals spent significantly more time in the novel environment relative to the familiar environment. In these same animals, horizontal and vertical activity rates were lower in the novel environment than in the familiar environment. In Experiments 2-5, animals were assessed for novelty preference behavior under the influence of either morphine (0, 0.1, 0.3, 1.0 or 3.0 mg/kg), naltrexone (0, 0.1, 0.3 or 1.0 mg/kg), amphetamine (0, 0.1, 0.3 or 1.0 mg/kg) or haloperidol (0, 0.03, 0.1, 0.3 or 1.0 mg/kg). Haloperidol produced a dose-dependent disruption in novelty preference behavior, while all other drugs tested were without effect. Haloperidol also disrupted the novelty-induced decrease in horizontal and vertical activity rates. These results suggest that haloperidol blocks the reinforcing and locomotor-depressant effects of a novel environment in a free-choice preference test.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2544904     DOI: 10.1016/0091-3057(89)90018-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  26 in total

1.  The effects of a serotoninergic substrate of the nucleus accumbens on latent inhibition.

Authors:  L V Loskutova
Journal:  Neurosci Behav Physiol       Date:  2001 Jan-Feb

2.  Preferences for cocaine- or pup-associated chambers differentiates otherwise behaviorally identical postpartum maternal rats.

Authors:  Brandi J Mattson; Sharon E Williams; Jay S Rosenblatt; Joan I Morrell
Journal:  Psychopharmacology (Berl)       Date:  2003-02-27       Impact factor: 4.530

3.  Changes in expression of c-Fos protein following cocaine-cue extinction learning.

Authors:  B Á Nic Dhonnchadha; B F Lovascio; N Shrestha; A Lin; K A Leite-Morris; H Y Man; G B Kaplan; K M Kantak
Journal:  Behav Brain Res       Date:  2012-06-18       Impact factor: 3.332

4.  Limited physical contact through a mesh barrier is sufficient for social reward-conditioned place preference in adolescent male rats.

Authors:  Natalie A Peartree; Lauren E Hood; Kenneth J Thiel; Federico Sanabria; Nathan S Pentkowski; Kayla N Chandler; Janet L Neisewander
Journal:  Physiol Behav       Date:  2011-10-08

5.  Novel cues reinstate cocaine-seeking behavior and induce Fos protein expression as effectively as conditioned cues.

Authors:  Ryan M Bastle; Peter R Kufahl; Mari N Turk; Suzanne M Weber; Nathan S Pentkowski; Kenneth J Thiel; Janet L Neisewander
Journal:  Neuropsychopharmacology       Date:  2012-04-25       Impact factor: 7.853

6.  Within-animal comparisons of novelty and cocaine neuronal ensemble overlap in the nucleus accumbens and prefrontal cortex.

Authors:  Natalie N Nawarawong; Christopher M Olsen
Journal:  Behav Brain Res       Date:  2019-10-12       Impact factor: 3.332

7.  Intraventricular administration of neuropeptide S has reward-like effects.

Authors:  Junran Cao; Luis de Lecea; Satoshi Ikemoto
Journal:  Eur J Pharmacol       Date:  2011-02-22       Impact factor: 4.432

8.  Exposure to pups influences the strength of maternal motivation in virgin female rats.

Authors:  Katharine M Seip; Joan I Morrell
Journal:  Physiol Behav       Date:  2008-09-09

9.  Operant sensation seeking engages similar neural substrates to operant drug seeking in C57 mice.

Authors:  Christopher M Olsen; Danny G Winder
Journal:  Neuropsychopharmacology       Date:  2009-01-14       Impact factor: 7.853

10.  Amphetamine administration into the ventral striatum facilitates behavioral interaction with unconditioned visual signals in rats.

Authors:  Rick Shin; Junran Cao; Sierra M Webb; Satoshi Ikemoto
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.